534 related articles for article (PubMed ID: 26538619)
1. Colony stimulating factor 1 receptor inhibition delays recurrence of glioblastoma after radiation by altering myeloid cell recruitment and polarization.
Stafford JH; Hirai T; Deng L; Chernikova SB; Urata K; West BL; Brown JM
Neuro Oncol; 2016 Jun; 18(6):797-806. PubMed ID: 26538619
[TBL] [Abstract][Full Text] [Related]
2. CSF-1R inhibition alters macrophage polarization and blocks glioma progression.
Pyonteck SM; Akkari L; Schuhmacher AJ; Bowman RL; Sevenich L; Quail DF; Olson OC; Quick ML; Huse JT; Teijeiro V; Setty M; Leslie CS; Oei Y; Pedraza A; Zhang J; Brennan CW; Sutton JC; Holland EC; Daniel D; Joyce JA
Nat Med; 2013 Oct; 19(10):1264-72. PubMed ID: 24056773
[TBL] [Abstract][Full Text] [Related]
3. Microglial stimulation of glioblastoma invasion involves epidermal growth factor receptor (EGFR) and colony stimulating factor 1 receptor (CSF-1R) signaling.
Coniglio SJ; Eugenin E; Dobrenis K; Stanley ER; West BL; Symons MH; Segall JE
Mol Med; 2012 May; 18(1):519-27. PubMed ID: 22294205
[TBL] [Abstract][Full Text] [Related]
4. Colony-Stimulating Factor 1 Receptor Blockade Inhibits Tumor Growth by Altering the Polarization of Tumor-Associated Macrophages in Hepatocellular Carcinoma.
Ao JY; Zhu XD; Chai ZT; Cai H; Zhang YY; Zhang KZ; Kong LQ; Zhang N; Ye BG; Ma DN; Sun HC
Mol Cancer Ther; 2017 Aug; 16(8):1544-1554. PubMed ID: 28572167
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin E2 transactivates the colony-stimulating factor-1 receptor and synergizes with colony-stimulating factor-1 in the induction of macrophage migration via the mitogen-activated protein kinase ERK1/2.
Digiacomo G; Ziche M; Dello Sbarba P; Donnini S; Rovida E
FASEB J; 2015 Jun; 29(6):2545-54. PubMed ID: 25757564
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic applications of macrophage colony-stimulating factor-1 (CSF-1) and antagonists of CSF-1 receptor (CSF-1R) signaling.
Hume DA; MacDonald KP
Blood; 2012 Feb; 119(8):1810-20. PubMed ID: 22186992
[TBL] [Abstract][Full Text] [Related]
7. Blockade of TGF-β signaling by the TGFβR-I kinase inhibitor LY2109761 enhances radiation response and prolongs survival in glioblastoma.
Zhang M; Kleber S; Röhrich M; Timke C; Han N; Tuettenberg J; Martin-Villalba A; Debus J; Peschke P; Wirkner U; Lahn M; Huber PE
Cancer Res; 2011 Dec; 71(23):7155-67. PubMed ID: 22006998
[TBL] [Abstract][Full Text] [Related]
8. Glioblastoma-derived Macrophage Colony-stimulating Factor (MCSF) Induces Microglial Release of Insulin-like Growth Factor-binding Protein 1 (IGFBP1) to Promote Angiogenesis.
Nijaguna MB; Patil V; Urbach S; Shwetha SD; Sravani K; Hegde AS; Chandramouli BA; Arivazhagan A; Marin P; Santosh V; Somasundaram K
J Biol Chem; 2015 Sep; 290(38):23401-15. PubMed ID: 26245897
[TBL] [Abstract][Full Text] [Related]
9. A unique anti-CD115 monoclonal antibody which inhibits osteolysis and skews human monocyte differentiation from M2-polarized macrophages toward dendritic cells.
Haegel H; Thioudellet C; Hallet R; Geist M; Menguy T; Le Pogam F; Marchand JB; Toh ML; Duong V; Calcei A; Settelen N; Preville X; Hennequi M; Grellier B; Ancian P; Rissanen J; Clayette P; Guillen C; Rooke R; Bonnefoy JY
MAbs; 2013; 5(5):736-47. PubMed ID: 23924795
[TBL] [Abstract][Full Text] [Related]
10. JNJ-28312141, a novel orally active colony-stimulating factor-1 receptor/FMS-related receptor tyrosine kinase-3 receptor tyrosine kinase inhibitor with potential utility in solid tumors, bone metastases, and acute myeloid leukemia.
Manthey CL; Johnson DL; Illig CR; Tuman RW; Zhou Z; Baker JF; Chaikin MA; Donatelli RR; Franks CF; Zeng L; Crysler C; Chen Y; Yurkow EJ; Boczon L; Meegalla SK; Wilson KJ; Wall MJ; Chen J; Ballentine SK; Ott H; Baumann C; Lawrence D; Tomczuk BE; Molloy CJ
Mol Cancer Ther; 2009 Nov; 8(11):3151-61. PubMed ID: 19887542
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of colony-stimulating-factor-1 signaling in vivo with the orally bioavailable cFMS kinase inhibitor GW2580.
Conway JG; McDonald B; Parham J; Keith B; Rusnak DW; Shaw E; Jansen M; Lin P; Payne A; Crosby RM; Johnson JH; Frick L; Lin MH; Depee S; Tadepalli S; Votta B; James I; Fuller K; Chambers TJ; Kull FC; Chamberlain SD; Hutchins JT
Proc Natl Acad Sci U S A; 2005 Nov; 102(44):16078-83. PubMed ID: 16249345
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of colony stimulating factor-1 receptor improves antitumor efficacy of BRAF inhibition.
Mok S; Tsoi J; Koya RC; Hu-Lieskovan S; West BL; Bollag G; Graeber TG; Ribas A
BMC Cancer; 2015 May; 15():356. PubMed ID: 25939769
[TBL] [Abstract][Full Text] [Related]
13. The promotion of breast cancer metastasis caused by inhibition of CSF-1R/CSF-1 signaling is blocked by targeting the G-CSF receptor.
Swierczak A; Cook AD; Lenzo JC; Restall CM; Doherty JP; Anderson RL; Hamilton JA
Cancer Immunol Res; 2014 Aug; 2(8):765-76. PubMed ID: 25005824
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of CSF-1R supports T-cell mediated melanoma therapy.
Sluijter M; van der Sluis TC; van der Velden PA; Versluis M; West BL; van der Burg SH; van Hall T
PLoS One; 2014; 9(8):e104230. PubMed ID: 25110953
[TBL] [Abstract][Full Text] [Related]
15. Colony-Stimulating Factor 1 Receptor Antagonists Sensitize Human Immunodeficiency Virus Type 1-Infected Macrophages to TRAIL-Mediated Killing.
Cunyat F; Rainho JN; West B; Swainson L; McCune JM; Stevenson M
J Virol; 2016 Jul; 90(14):6255-6262. PubMed ID: 27122585
[TBL] [Abstract][Full Text] [Related]
16. Activities of granulocyte-macrophage colony-stimulating factor and interleukin-3 on monocytes.
Suzuki H; Katayama N; Ikuta Y; Mukai K; Fujieda A; Mitani H; Araki H; Miyashita H; Hoshino N; Nishikawa H; Nishii K; Minami N; Shiku H
Am J Hematol; 2004 Apr; 75(4):179-89. PubMed ID: 15054806
[TBL] [Abstract][Full Text] [Related]
17. Distinct roles of CSF family cytokines in macrophage infiltration and activation in glioma progression and injury response.
Sielska M; Przanowski P; Wylot B; Gabrusiewicz K; Maleszewska M; Kijewska M; Zawadzka M; Kucharska J; Vinnakota K; Kettenmann H; Kotulska K; Grajkowska W; Kaminska B
J Pathol; 2013 Jul; 230(3):310-21. PubMed ID: 23520016
[TBL] [Abstract][Full Text] [Related]
18. The tumor microenvironment underlies acquired resistance to CSF-1R inhibition in gliomas.
Quail DF; Bowman RL; Akkari L; Quick ML; Schuhmacher AJ; Huse JT; Holland EC; Sutton JC; Joyce JA
Science; 2016 May; 352(6288):aad3018. PubMed ID: 27199435
[TBL] [Abstract][Full Text] [Related]
19. Colony-stimulating factor-1 blockade by antisense oligonucleotides and small interfering RNAs suppresses growth of human mammary tumor xenografts in mice.
Aharinejad S; Paulus P; Sioud M; Hofmann M; Zins K; Schäfer R; Stanley ER; Abraham D
Cancer Res; 2004 Aug; 64(15):5378-84. PubMed ID: 15289345
[TBL] [Abstract][Full Text] [Related]
20. Preclinical evaluation of 3D185, a novel potent inhibitor of FGFR1/2/3 and CSF-1R, in FGFR-dependent and macrophage-dominant cancer models.
Peng X; Hou P; Chen Y; Dai Y; Ji Y; Shen Y; Su Y; Liu B; Wang Y; Sun D; Jiang Y; Zha C; Xie Z; Ding J; Geng M; Ai J
J Exp Clin Cancer Res; 2019 Aug; 38(1):372. PubMed ID: 31438996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
